Current Opinion in Urology

Papers
(The TQCC of Current Opinion in Urology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Electrosurgery or laser for benign prostatic enlargement: trumpcard or pitfalls47
Long-term outcome of urethral and genital reconstruction in hypospadias and exstrophy-epispadias complex36
Editorial introductions29
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments25
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies20
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects19
Research frontiers in urology19
Editorial: Medical, technical and functional aspect of various types of urinary diversion18
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update18
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis17
The role of innovations in advancing urologic oncologic patient care17
The adverse impact of COVID-19 on men's health16
Best nonsurgical managements of acute urinary retention: what's new?16
Exploring the impact of artificial intelligence–enabled decision aids in improving patient inclusivity, empowerment, and education in urology: a systematic review by EAU endourology15
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker15
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma15
Editorial introductions14
Editorial introductions14
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma14
Testicular cancer with small metastatic burden: optimal approach in 202414
Editorial introductions13
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder13
RNA-based urinary assays for non-muscle invasive bladder cancer13
Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations12
Tissue-based gene expression testing in localized prostate cancer12
Sustainable practices in hospital and operating theaters11
Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?10
Sexually transmitted infections and the vaginal microbiome after vaginoplasty10
Perioperative systemic therapy, current paradigm and ongoing clinical trials in upper tract urothelial cancer10
Risk of dementia associated with the use of anticholinergic medications: a review of recent literature10
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints9
Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors9
Optimizing clinical risk stratification of localized prostate cancer9
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects8
Update on classification of oncocytic neoplasms of the kidney8
Brief update of the new WHO classification for urothelial carcinoma8
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging8
Should endoscopic laser excision be offered as the first-line management for patients with eroded mesh? Outcomes of a systematic review of literature8
Metabolic syndrome, obesity and cancer risk8
Is there a role for metastasis-directed therapy in bladder cancer?8
Preoperative geriatric assessment of urological patients: a narrative review8
Minimally invasive surgery for benign prostatic obstruction: new insights and future technical standards7
Management of vaginoplasty canal complications7
The role of surgery for locally advanced urothelial cancers7
Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities7
State of the art on stress incontinence management after benign prostatic obstruction surgery7
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer7
Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma7
Decoding germ cell tumours for clinicians7
Preoperative patient optimization for endourological procedures: the current best clinical practice7
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors7
Alternatives to whole gland treatment for localized prostate cancer: a review of novel focal therapies7
Are robots the future? A case for robotic pyeloplasty as the gold standard treatment in ureteropelvic junction obstruction6
Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis6
Upper tract urothelial carcinoma: conservative management - intraluminal adjuvant therapy, and surveillance6
Patient-reported outcomes in genital gender-affirming surgery6
Toxicities of taxane-based chemotherapy in prostate cancer6
Retrograde intra renal surgery and safety: pressure and temperature. A systematic review6
Editorial introductions6
Management of upper urinary tract problems after radical cystectomy for urothelial carcinoma: tips and tricks5
Advanced sperm tests and impact on clinical male factor management5
Medical therapy for male infertility5
Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer5
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes5
Implications and effects of COVID-19 on diagnosis and management of prostate cancer5
Liquid biomarkers in prostate cancer: recent advancements and future directions5
Metastasis-directed therapy in oligometastatic and oligoprogressive renal cell carcinoma5
Innovative systemic therapies for penile cancer5
Use of genomic markers to improve epidemiologic and clinical research in urology5
AI-powered radiomics: revolutionizing detection of urologic malignancies5
Lasers for benign prostatic hyperplasia (hybrid, blue diode, TFL, Moses). Which one to choose?5
Editorial introductions5
Prevention, diagnosis, and treatment of urolithiasis in geriatric patients - differences, similarities and caveats in comparison to the general population4
Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis4
Digital health innovations in urology: telemedicine, wearables, and mobile applications – a systematic review of literature4
Percutaneous management of caliceal diverticula: a narrative review4
Metabolic evaluation: is there really a future?4
Editorial introductions4
New technologies for nephron-sparing surgery in upper urinary tract cancers4
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era4
Editorial: Future of kidney stone management4
Update on the management of complex strictures of the bulbar urethra4
Preclinical models for bladder cancer therapy research4
Toxicities of radioligand and radioisotope therapy in prostate cancer: a systematic review and meta-analysis4
The use of MRI in urothelial carcinoma4
Cost-effectiveness of serum, urine, and tissue-based prostate cancer biomarkers4
Editorial introductions4
Management of stage I testicular cancer4
The environmental impacts of anesthesia4
Detection of urological cancers by the signature of organic volatile compounds in urine, from dogs to electronic noses4
Editorial introductions4
Inflammation and kidney stones: cause and effect?4
Overlooked and underserved: how healthcare fails men in the pursuit of equity4
Surgical management of testicular cancer with limited retroperitoneal disease4
Integration of novel artificial intelligence tools in pediatric urologic practice4
Organ storage in renal transplantation4
Role of cytoreductive surgery in the era of immunotherapy4
Genetics of testicular cancer: a review4
0.070276975631714